lab-on-a-chip | GenomeWeb

lab-on-a-chip

Drop to Drop

Not every drop of blood is the same, according to researchers from Rice University.

The San Diego-based firm will use the Series C investment and convertible debt to land regulatory clearance for its cancer treatment response assay.

NEW YORK (GenomeWeb) – Contract research organization Nanosyn today announced a multiyear research service agreement to provide its microfluidics screening and profiling capabilities to Forma Therapeutics.

NEW YORK (GenomeWeb News) – A consortium of European research institutions and private partners will use €5.3 million ($7.4 million) in funding to develop a microfluidics-based lab-on-a-chip device to identify and measure the concentration of circulating tumor cells in blood, one of the partners,

NEW YORK (GenomeWeb News) – The Johns Hopkins University and Imec today announced a collaboration to "expand healthcare applications" for silicon nanotechnology.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with the US Food and Drug Administration on food testing applications.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Siemens has put its lab-on-a-chip technology up for sale.

ADA will develop the technology to identify biological hazards in complex matrices.

Devised by scientists from Zhejiang University, the prototype device integrates nucleic acid purification, isothermal amplification, and fluorescence detection on a single glass chip, and can in principle detect DNA from complex biological matrices such as blood.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.